title: A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection.
abstract: Kerion celsi is the inflammatory extreme of tinea capitis, representing a delayed hypersensitivity reaction to the causative dermatophyte. Some authors have advocated the use of oral corticosteroids in patients with kerion formation to inhibit the host inflammatory response and minimize the risk of scarring. This retrospective study analyzed the management and outcome of all children younger than 10 years old presenting to our pediatric dermatology service with tinea capitis resulting in kerion formation between 2003 and 2009. We propose that kerion treatment be directed toward the underlying dermatophyte. Oral and intralesional corticosteroids are an unnecessary adjunct to oral antifungal therapy for children with tinea capitis presenting with kerion in urban areas.
authors.affiliation: Department of Dermatology, King's College Hospital, London, UK.
authors.forename: Laura E
authors.initials: LE
authors.lastname: Proudfoot
authors.affiliation: Department of Dermatology, King's College Hospital, London, UK.
authors.forename: Elisabeth M
authors.initials: EM
authors.lastname: Higgins
authors.affiliation: Department of Dermatology, King's College Hospital, London, UK.
authors.forename: Rachael
authors.initials: R
authors.lastname: Morris-Jones
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D003883:Arthrodermataceae / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D002921:Cicatrix / Q000517:prevention & control; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012189:Retrospective Studies; D012720:Severity of Illness Index; D014006:Tinea Capitis / Q000188:drug therapy*; D016896:Treatment Outcome; D014249:Trichophyton / Q000187:drug effects*
chemical_list: D000305:Adrenal Cortex Hormones; D000935:Antifungal Agents
references.citation: Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J 1999;18:180-185.
references.citation: Fuller LC, Child FJ, Midgley G et al. Diagnosis and management of scalp ringworm. BMJ 2003;326:539-541.
references.citation: Rosenthal T. Aulus Cornelius Celsus. Arch Dermatol 1961;84:613-618.
references.citation: Birt AR, Wilt JC. Mycology, bacteriology and histopathology of suppurative ringworm. Arch Derm Syphilol 1954;69:441-448.
references.citation: Rasmussen JE, Ahmed AR. Trichophytin reactions in children with tinea capitis. Arch Dermatol 1978;114:371-372.
references.citation: Babel DE, Rogers AL, Beneke ES. Dermatophytosis of the scalp - incidence, immunoresponse and epidemiology. Mycopathologia 1990;109:69-73.
references.citation: Gibbon KL, Goldsmith P, Salisbury KA et al. Unnecessary surgical treatment of fungal kerions in children. BMJ 2000;320:696-697.
references.citation: O’Brien M, Allen H, Dolder S. A new paradigm in the treatment of kerions: treat the inflammation. 2009;P206. AAD.
references.citation: Laude TA, Shah BR, Lynfield Y. Tinea capitis in Brooklyn. Am J Dis Child 1982;136:1047-1050.
references.citation: Keipert JA. Beneficial effect of corticosteroid therapy in microsporum canis kerion. Australas J Dermatol 1984;25:127-130.
references.citation: Annabel M, Hubert L, Jacques C et al. Traitement de 2 cas de kérions par griséofulvine et corticoïds oraux. Arch Pediatr 2009;16:1464-1466.
references.citation: Hussain I, Muzaffar F, Rashid T et al. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med Mycol 1999;37:97-99.
references.citation: Ginsburg CM, Gan VN, Petruska M. Randomized controlled trial of intralesional corticosteroid and griseofulvin vs griseofulvin alone for treatment of kerion. Pediatr Infect Dis J 1987;6:1084-1087.
references.citation: Honig PJ, Caputo GL, Leyden JJ et al. Treatment of kerions. Pediatr Dermatol 1994;11:69-71.
references.citation: Gonzalez U, Seaton T, Bergus G et al. Systemic antifungal therapy for tinea capitis in children. Cochrane database Syst Rev 2007;4:CD004685.
references.citation: Gupta AK, Adamiak A, Cooper EA. The efficacy and safety of terbinafine in children. J Eur Acad Dermatol 2003;17:627-640.